| Literature DB >> 29283402 |
Michael Lenning1, Joseph Fortunato2, Tai Le3, Isaac Clark4, Ang Sherpa5, Soyeon Yi6, Peter Hofsteen7, Geethapriya Thamilarasu8, Jingchun Yang9, Xiaolei Xu10, Huy-Dung Han11, Tzung K Hsiai12, Hung Cao13,14.
Abstract
Heart disease is the leading cause of mortality in the U.S. with approximately 610,000 people dying every year. Effective therapies for many cardiac diseases are lacking, largely due to an incomplete understanding of their genetic basis and underlying molecular mechanisms. Zebrafish (Danio rerio) are an excellent model system for studying heart disease as they enable a forward genetic approach to tackle this unmet medical need. In recent years, our team has been employing electrocardiogram (ECG) as an efficient tool to study the zebrafish heart along with conventional approaches, such as immunohistochemistry, DNA and protein analyses. We have overcome various challenges in the small size and aquatic environment of zebrafish in order to obtain ECG signals with favorable signal-to-noise ratio (SNR), and high spatial and temporal resolution. In this paper, we highlight our recent efforts in zebrafish ECG acquisition with a cost-effective simplified microelectrode array (MEA) membrane providing multi-channel recording, a novel multi-chamber apparatus for simultaneous screening, and a LabVIEW program to facilitate recording and processing. We also demonstrate the use of machine learning-based programs to recognize specific ECG patterns, yielding promising results with our current limited amount of zebrafish data. Our solutions hold promise to carry out numerous studies of heart diseases, drug screening, stem cell-based therapy validation, and regenerative medicine.Entities:
Keywords: ECG pattern recognition; electrocardiogram (ECG); heart diseases; machine learning; phenotype screening; real-time monitoring; zebrafish
Mesh:
Year: 2017 PMID: 29283402 PMCID: PMC5796315 DOI: 10.3390/s18010061
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1(a) Fabrication processes of the MEA membranes; (b) Different electrode sizes and the complete device; (c) Impedance characterization curves of one 300-µm MEA membrane; (d) The MEA on fish.
Figure 2Apparatus formation and the measurement setup.
Figure 3(a) The in-house Faraday cage; (b,c) Ambient EMI without and with Faraday cage.
Figure 4LabVIEW program flowchart.
Figure 5K-means clustering algorithm.
Figure 6ECG signals, raw (upper) and de-noised (lower), recorded from an awake fish, using our newly developed PDMS apparatus.
Figure 7(a) Main program front panel with filtered ECG data, marked ECG components, and anomaly diagnosis information; (b) Unfiltered and filtered zebrafish ECG data with ECG components identified.
Summary table of anomalies detected in the ECG signal presented in Figure 7a.
| R-R Interval Number | Anomaly/Anomalies |
|---|---|
| 1–2 | Bradycardia |
| 3–41 | Bradycardia, Arrhythmia |
Figure 8Exemplary standard ECG patterns and exemplary conversion images for CNN training to indicate general differences in the presentation of wave morphology. (a) Control fish; (b–d) Mutant lines with phenotypes of AVB, SA and STE, respectively. Green: R peaks; Pink: P peaks.
Figure 9(a) The confusion matrix for k-means clustering-based classification; (b) The confusion matrix for CNN-based classification.
Classifier results.
| Abnormality | Precision | Recall | F1 | |||
|---|---|---|---|---|---|---|
| K-Means | CNN | K-Means | CNN | K-Means | CNN | |
| AV Block | 0.78 | 0.95 | 0.70 | 0.89 | 0.74 | 0.92 |
| ST Elevation | 0.8 | 0.98 | 0.80 | 0.96 | 0.80 | 0.97 |
| SA | 0.73 | 0.86 | 0.80 | 0.95 | 0.76 | 0.90 |
| Average | 0.77 | 0.94 | 0.77 | 0.93 | 0.77 | 0.93 |